Dupilumab Is Effective in Patients With Moderate-to-Severe Uncontrolled GINA-Defined Type 2 Asthma Irrespective of an Allergic Asthma Phenotype

Klaus F. Rabe, J. Mark FitzGerald, Eric D. Bateman, Mario Castro, Ian Pavord, Jorge Máspero, William W. Busse, Kenji Izuhara, Nadia Daizadeh, Benjamin Ortiz, Nami Pandit‐Abid, Paul J. Rowe, Yamo Deniz

2022The Journal of Allergy and Clinical Immunology In Practice24 citationsDOI

Topics & Concepts

AsthmaExhaled nitric oxideMedicineAeroallergenPlaceboDupilumabImmunologyAllergyEosinophilImmunoglobulin EBenralizumabInternal medicineAllergic asthmaGastroenterologyBronchoconstrictionAllergenAntibodyPathologyMepolizumabAlternative medicineAsthma and respiratory diseasesIL-33, ST2, and ILC PathwaysDelphi Technique in Research